Abstract:Amyloid β (Aβ) is a key molecule in the pathogenesis of Alzheimer's disease, but its physiological function remains unclear. It is known that high levels of cellular cholesterol enhance Aβ production and therefore cholesterol is a risk factor for Alzheimer's disease. This linkage led us to hypothesize that Aβ is produced to regulate cellular cholesterol levels in response to high cholesterol stimulation. To test this hypothesis, we examined effects of Aβ secretion from cells on cellular cholesterol levels and cholesterol efflux from cells. We also studied possible roles of Aβ in cholesterol transport from the brain to the periphery by injecting reconstituted lipoproteins with or without Aβ into the cerebral ventricle of APP knockout mice. After injection, the distribution of the injected radio-labeled cholesterols in the brain and peripheral tissues was determined. Aβ secretion from cells caused a reduction of cellular cholesterol levels, which was accompanied with an increase in efflux of cholesterol from cells. Immunoelectron microscopic observation of the culture media revealed that Aβ assembled high-density lipoprotein-like particles during its secretion. This assembly was mediated by cellular ATP-binding cassette transporter A1. In the injection study, reconstituted lipoproteins containing Aβ were excreted from the brain into the peripheral tissues more efficiently than those without Aβ. These results suggest that Aβ mediates cholesterol efflux from cells and furthermore cholesterol transport from the brain to the circulation. Based on these findings, we propose a novel, apolipoprotein-like function for Aβ that is involved in maintenance of cellular and cerebral cholesterol homeostasis.

P1‐242: Regulation of cholesterol efflux by amyloid β secretion